Post-Treatment Lyme Disease: What the Research Shows

You finished the antibiotics. The rash faded, the doctor signed off, and on paper the Lyme is gone. But weeks later you’re still wiped out by noon, your knees ache on the stairs, and you keep losing the thread of a sentence halfway through. If that describes you or someone in your house, you are not imagining it, and you are not alone in Maine. This is one of the more confusing corners of tickborne illness, and the research has more to say about it than most people realize.

What “post-treatment Lyme” actually means

Doctors have a name for this pattern: post-treatment Lyme disease syndrome, or PTLDS. The National Institute of Allergy and Infectious Diseases describes it as a collection of symptoms, such as pain, fatigue, and trouble thinking or brain fog, that stick around for more than six months after a person finishes the standard course of antibiotics for Lyme.

The six-month line matters. Plenty of people feel run down for a few weeks after any infection. PTLDS is the smaller group whose symptoms outlast that window and start to interfere with everyday life. It’s a recognized clinical picture, not a vague catch-all.

You’ll also hear the phrase “chronic Lyme.” It gets used loosely, and that looseness causes real trouble, which we’ll get to. For now, the cleaner term for what research describes is post-treatment Lyme disease syndrome.

How common is it, really

Here the numbers depend on who’s counting and how. NIAID estimates that roughly 10 to 20 percent of people treated for Lyme go on to have lingering symptoms, and European studies report similar ranges. That sounds like a lot.

The CDC frames it more conservatively. On its chronic-symptoms page, the agency notes that six months after treatment, fatigue, body aches, and difficulty thinking are about 5 to 10 percent more common in people who have had Lyme than in people who haven’t. In other words, some of what gets blamed on Lyme is background noise that shows up in the general population too. The extra burden specifically tied to a prior infection is real but smaller than the headline percentages suggest.

A different angle comes from insurance records. Researchers writing in eBioMedicine in 2023 combed through claims covering more than 63 million people and identified 44,420 Lyme cases and 1,518 that met a PTLDS definition, a ratio of about 3.4 percent. Those patients also showed measurably higher odds of certain chronic conditions, including anemia and osteoarthrosis. So PTLDS is a real subset of treated cases, just a smaller one than the scariest figures imply.

Why Mainers should pay attention

Maine has more skin in this than almost any state. It set a record in 2024 with 3,218 Lyme disease cases reported, according to the Maine CDC, up from roughly 2,940 the year before. Back in 2023, Maine’s incidence rate of about 213 cases per 100,000 people put it in the top three states in the country, alongside Rhode Island and Vermont.

The midcoast carries especially high tickborne-disease rates, and the University of Maine’s tick lab has noted something that should give every gardener and trail runner pause. After a string of mild winters, deer ticks have been turning up at the lab in all twelve months of the year. The season that used to bracket spring and fall now barely has a hard edge. More bites means more Lyme, and more Lyme means more people facing the question of what to do when symptoms refuse to quit.

If you want the wider picture on local risk and prevention, our complete Maine and New Hampshire tick and Lyme guide covers the landscape. This piece is the deep dive on what happens after treatment.

The symptoms research keeps describing

Across studies, the same cluster shows up. The Johns Hopkins Lyme Disease Research Center defines post-treatment Lyme as patients who stay significantly ill six months or more after standard antibiotic therapy, and lists the hallmarks: severe fatigue, musculoskeletal pain, sleep disturbance, and cognitive problems such as trouble with short-term memory, processing speed, or juggling more than one task at a time.

None of these are dramatic in the way a high fever is. That’s part of why the condition gets dismissed. The fatigue isn’t “I could use a nap” tired. The brain fog isn’t ordinary forgetfulness.

And it adds up. A 2017 study in Frontiers in Medicine, led by Rebman, looked at a carefully defined group of PTLDS patients and found they were highly symptomatic with poor health-related quality of life, scoring worse on fatigue, pain, sleep, and depression than healthy people who’d never had Lyme. The takeaway is blunt: for the people who land in this category, the toll on daily functioning is genuine and measurable.

What scientists think is driving it

Here’s the honest answer. Nobody knows for sure. The CDC says plainly that the cause of these symptoms is currently unknown.

NIAID lays out the leading hypotheses without picking a winner: lingering inflammation, an immune response that the original infection set off and that never fully switched back off, possible co-infections from the same tick bite, or a post-infectious syndrome similar to what’s seen after other infections. The thread connecting most of these is that they don’t require live bacteria still multiplying in the body. The infection may be long gone while the body’s reaction to it keeps going.

That distinction is the whole reason the CDC discourages the term “chronic Lyme.” The phrase implies an ongoing, active bacterial infection that needs to be hunted down and killed. The evidence doesn’t support that picture for most people, and acting as if it does leads somewhere risky.

The long-term antibiotics question

If symptoms linger, why not just keep taking antibiotics until they clear? It’s an intuitive idea. It has been tested, repeatedly, and it doesn’t hold up.

The CDC’s summary is direct: extended treatment with antibiotics is no better than placebo for curing prolonged symptoms. A 2024 systematic review in the European Journal of Neurology, by Dersch and colleagues, pooled eight randomized controlled trials and found no benefit for quality of life, depression, cognition, or fatigue, while patients on the longer courses had more adverse events.

Those adverse events aren’t trivial. The CDC warns that long-term antibiotic use has been linked to serious, even deadly complications, such as sepsis or colitis. Putting in months on a drug that trials show won’t help, and that carries real downside, is a poor trade.

This is where the major medical societies landed too. The 2020 joint guideline from the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology recommends against additional antibiotic therapy for patients with persistent, nonspecific symptoms who lack objective evidence of an active infection. That’s a strong recommendation, and it reflects the same body of trial data.

Which is also why accurate diagnosis up front matters so much. Lyme testing has real limits, especially early on, and a clear understanding of what the labs can and can’t tell you helps everyone avoid chasing the wrong target. Our explainers on how accurate Lyme testing is and on spotting the early rash go deeper on getting that first call right.

The part worth holding onto: most people get better

It would be easy to read all of this and feel stuck. The science actually points the other way for the majority.

The CDC’s own language is reassuring: patients with prolonged symptoms due to Lyme usually get better over time without additional antibiotics, though it can take many months to feel completely well. Recovery is slow, not absent.

A NIAID-supported study published in 2023 followed 102 children treated for Lyme and found that about 75 percent had fully recovered within six months of finishing treatment. Kids aren’t adults, and a slower curve for some grown-ups is expected. But the overall direction is encouraging, and it runs against the fear that lingering symptoms mean a permanent condition.

So the realistic picture for a Mainer in this spot looks something like this. A real syndrome exists, with real symptoms that deserve to be taken seriously by a clinician. The cause is still being worked out. Long courses of antibiotics are not the answer and can cause harm. And patience, frustrating as it is, is on your side, because most people climb back to themselves given time.

If you’re in the thick of it, that last point is the one to carry with you on the bad days.

Sources

• National Institute of Allergy and Infectious Diseases (NIAID), NIH. NIH Awards Will Fund Post-Treatment Lyme Disease Syndrome Research (PTLDS definition, 10 to 20 percent estimate, and leading hypotheses). 2023. https://www.nih.gov/news-events/news-releases/nih-awards-will-fund-post-treatment-lyme-disease-syndrome-research
• Centers for Disease Control and Prevention. Chronic Symptoms and Lyme Disease. 2024. https://www.cdc.gov/lyme/signs-symptoms/chronic-symptoms-and-lyme-disease.html
• Dersch, R., et al. Treatment of post-treatment Lyme disease symptoms: a systematic review. European Journal of Neurology. 2024. https://onlinelibrary.wiley.com/doi/full/10.1111/ene.16293
• Johns Hopkins Medicine Lyme Disease Research Center. Treatment and Prognosis of Lyme Disease. 2024. https://www.hopkinslyme.org/lyme-disease/treatment-and-prognosis-of-lyme-disease/
• Rebman, A. W., et al. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome. Frontiers in Medicine. 2017. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2017.00224/full
• IDSA, AAN, and ACR. Clinical Practice Guidelines: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Clinical Infectious Diseases. 2021. https://academic.oup.com/cid/article/72/1/e1/6010652
• Monaghan M, et al. (NIAID-supported). Pediatric Lyme disease: systematic assessment of post-treatment symptoms and quality of life (102 children; most recovered within six months). Pediatric Research. 2024. https://pubmed.ncbi.nlm.nih.gov/36997691/
• Chung, J., et al. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data. eBioMedicine. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10114153/
• Maine Public (citing Maine CDC). Maine reported record-high number of tickborne disease cases last year. 2025. https://www.mainepublic.org/health/2025-01-03/maine-reported-record-high-number-of-tickborne-disease-cases-last-year
• CDC MMWR. Surveillance for Lyme Disease After Implementation of a Revised Case Definition, United States, 2022. 2024. https://www.cdc.gov/mmwr/volumes/73/wr/mm7306a1.htm
• CDC. Lyme Disease Surveillance Data. 2024. https://www.cdc.gov/lyme/data-research/facts-stats/surveillance-data-1.html

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.